Business Segments — Selling, general and administrative expenses
Gilead Sciences Business Segments — Selling, general and administrative expenses decreased by 19.1% to $1.45B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.3%, from $1.26B to $1.45B. Over 3 years (FY 2022 to FY 2025), Business Segments — Selling, general and administrative expenses shows relatively stable performance with a 0.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A lower ratio of these expenses to total revenue indicates improved operating leverage and higher potential profitability.
Detailed definition
This metric represents the aggregate of all selling, marketing, and general administrative expenses required to support...
Peer comparison
Standard SG&A metric used across the pharmaceutical and biotechnology industry to benchmark operational efficiency.
gild_segment_reportable_segment_selling_general_and_administrative_expensesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.42B | $1.42B | $1.42B | $1.42B | $1.52B | $1.52B | $1.52B | $1.52B | $1.38B | $1.38B | $1.43B | $1.91B | $1.26B | $1.37B | $1.36B | $1.79B | $1.45B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +7.4% | +0.0% | +0.0% | +0.0% | -9.7% | +0.1% | +4.1% | +33.1% | -34.0% | +8.5% | -0.6% | +32.2% | -19.1% |
| YoY Change | — | — | — | — | +7.4% | +7.4% | +7.4% | +7.4% | -9.7% | -9.6% | -5.9% | +25.3% | -8.5% | -0.9% | -5.3% | -5.9% | +15.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's business segments — selling, general and administrative expenses?
- Gilead Sciences (GILD) reported business segments — selling, general and administrative expenses of $1.45B in Q1 2026.
- How has Gilead Sciences's business segments — selling, general and administrative expenses changed year-over-year?
- Gilead Sciences's business segments — selling, general and administrative expenses increased by 15.3% year-over-year, from $1.26B to $1.45B.
- What is the long-term trend for Gilead Sciences's business segments — selling, general and administrative expenses?
- Over 3 years (2022 to 2025), Gilead Sciences's business segments — selling, general and administrative expenses has grown at a 0.6% compound annual growth rate (CAGR), from $5.67B to $5.77B.
- What does business segments — selling, general and administrative expenses mean?
- The total combined cost of all non-production operating expenses.